Author Archives: Jeff Schindler

Pfizer and American Kennel Club Team Up For New Research

By Jeff Schindler | Published: September 8, 2010

Pfizer’s Animal Health unit has signed an exclusive deal with the American Kennel Club’s Canine Health Foundation (CHF)—the largest nonprofit worldwide—to fund health research exclusively for canines. This new research partnership names Pfizer Animal Health the sole biopharmaceutical partner of CHF, and begins with Pfizer committing to provide an initial $50,000 over a two-year period. According to [...]

Study: Future of Personalized Medicine

By Jeff Schindler | Published: July 27, 2010

An increased focus on targeted medicine has become a staple for all facets of healthcare, from drug developers to consumers to pharma companies. Gerson Lehrman and Bloomberg jointly commissioned a survey that gauged the reactions and predictions of this trend from 52 leading US physicians. The survey covered a number of topics to assess which [...]

Posted in R&D | Tagged Biotechnology and Pharmaceuticals, business, Health, Health care, Medicine, Personalized medicine, Physician, Research and development | 1 Comment

Weight-Loss Drug Qnexa Loses in FDA Committee Ruling

By Jeff Schindler | Published: July 16, 2010

Vivus’ Qnexa may help in weight loss, but it also now risks losing its place in the market following FDA’s Advisory Committee’s ruling July 15. The panel of medical experts did not question the effectiveness of the drug, but rather voiced its concerns over safety of the medication. The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee [...]

Posted in FDA, Safety | Tagged Anti-obesity medication, Drug, FDA, Fen-phen, Food and Drug Administration, Health, Qnexa, Weight loss | 3 Comments